Skip to main content

Matthew Luchini

Stock Analyst at BMO Capital

Total Price Targets
3
Stocks Covered
3
Sectors
Healthcare
Most Recent
Nov 12, 2021

Stocks Covered by Matthew Luchini

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
KODKodiak Sciences Inc.$114.00$44.09+158.5%1Nov 12, 2021
APLSApellis Pharmaceuticals, Inc.$69.00$40.95+68.5%1Nov 9, 2021
MDGLMadrigal Pharmaceuticals, Inc.$111.00$516.66-78.5%1Aug 6, 2021

Recent Activity

  • Nov 12, 2021— Set$114.00price target onKOD(Kodiak Sciences Inc.)
  • Nov 9, 2021— Set$69.00price target onAPLS(Apellis Pharmaceuticals, Inc.)
  • Aug 6, 2021— Set$111.00price target onMDGL(Madrigal Pharmaceuticals, Inc.)

Frequently Asked Questions

Who is Matthew Luchini?

Matthew Luchini is a stock analyst at BMO Capital covering 3 stocks primarily in Healthcare. They have issued 3 price targets since Aug 6, 2021.

What stocks does Matthew Luchini cover?

Matthew Luchini currently covers 3 stocks, including KOD, APLS, MDGL.

What is Matthew Luchini's latest price target?

Matthew Luchini's most recent price target was $114.00 on KOD (Kodiak Sciences Inc.), set on Nov 12, 2021.

What is Matthew Luchini's highest price target?

Matthew Luchini's highest issued price target is $114.00 on KOD, set on Nov 12, 2021.

More Analysts at BMO Capital

Keith Bachman
BMO Capital
Targets132
Stocks29
James Thalacker
BMO Capital
Targets85
Stocks23
John McNulty
BMO Capital
Targets75
Stocks21
Andrew Strelzik
BMO Capital
Targets68
Stocks25

Coverage based on publicly published price targets. Not investment advice.